Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. - Wikidata - wikimedia - TriplyDB

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

http://www.wikidata.org/entity/Q36431628

about

TERT promoter mutations in thyroid cancer Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's Thyroiditis High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma Recent incidences and differential trends of thyroid cancer in the USA.The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer.Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.Update on the cytologic features of papillary thyroid carcinoma variants.A six-genotype genetic prognostic model for papillary thyroid cancer.How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.Follicular morphological characteristics may be associated with invasion in follicular thyroid neoplasms with papillary-like nuclear features.Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas.Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?Defining Papillary Carcinoma of the Thyroid: A Short Review and Analysis.Differentiation of the Follicular Variant of Papillary Thyroid Carcinoma From Classic Papillary Thyroid Carcinoma: An Ultrasound Analysis and Complement to Fine-Needle Aspiration Cytology.BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment.Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.ZCCHC12, a novel oncogene in papillary thyroid cancer.Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma

P2860

Q26770808-C590C7E6-9075-4653-9CE1-AF3667F90C61 Q28274899-8C69648F-AADE-44CF-BBE8-6A3808D1A9EC Q33685745-E8368646-FCA1-4286-AFFF-DABE2FCD837B Q33884794-8619AC52-9E31-41C8-B82D-8655251B62BB Q35945841-CFD8D471-2962-4A02-866A-8A56EB6A29BD Q36328328-E2EBB533-65A0-4A78-8817-29776C9CD502 Q36963280-50212A6F-57EF-4A51-BFD1-ADFBA1855054 Q36980190-A10E962B-5A43-4005-8655-EA71E37051FE Q37127415-5CBECCC4-1EA8-4BCB-9945-CEDD8B77714F Q37694761-83A428F9-86EB-4DB4-8394-ADB00B4B2F53 Q37701580-B081C48D-DECA-41CC-B741-BA984115D080 Q37702380-24268910-7508-4319-BF93-133F356249DF Q38737374-5BB08C4F-9C32-4B85-86AA-2DA1EAB029F3 Q38743211-B3832C8D-E3E9-4373-910C-759BC18A3862 Q38865611-BBDB076E-7C78-4EFC-97D1-C114B23C1373 Q39163041-3092DC29-7B47-49E5-A198-DAE9DD088A88 Q39163637-F1D4568D-1674-4ED5-A431-41D509FF445F Q39732718-9760D434-D145-4EB0-8E52-7C24A79596A1 Q40044552-665150F0-3A19-47A9-BB8F-0352B879B32E Q41598114-DD250ACB-BA73-414C-A545-F2A54A25C898 Q42290503-6F9FA083-4BE2-4488-8058-1350EBE86FFD Q47097250-0CF2FACC-520A-403F-9AF0-834D85B9667D Q47295202-AFB8B7F3-464C-44E6-8A5E-8064A2527AE7 Q47313004-37B074E6-03F6-4260-B8CA-9A55CE3CF2A2 Q47317479-6814102A-EA44-4A60-B906-5E835EDE13CA Q47877478-6A0EFFFB-CBF7-4DF3-9B63-BEB6D7CC8F95 Q47996233-565752B6-EAFF-481D-B619-9B9C392C4BC9 Q48113122-4FF85D80-1CA2-4387-BBCC-D93DC3F52E01 Q49808093-D2F569E5-2E73-4DDB-B7CF-37D667614626 Q50146629-DB213DC2-239B-4C73-B637-7C0C7E75D9F5 Q52668580-BEE3D605-A2CF-4A7E-82E1-A216D2605F24 Q52838835-B6F54987-C8BB-481F-BE46-5C78E58CCC5F Q52878849-0182EFD1-2633-4C9E-B75A-AF00F997729D Q54967888-358F4321-046B-47BE-940E-91ACC1069C16 Q55325292-C24B4385-6C1B-492C-A531-E9314EBD0F9B Q57818908-C7F0B379-AF70-4CBF-912D-27788AC205B0 Q58804282-2A163DD9-8039-4ABC-B8FE-13B42198D562

P2860

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

http://www.wikidata.org/entity/Q36431628

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@ast

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@en

type

label

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@ast

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@en

prefLabel

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@ast

Differential Clinicopathologic ...... llary Thyroid Cancer Variants.

@en

P1433

Q36431628-5C54D99D-5BE5-41FB-B99B-EBB71513A6E3

P1476

Q36431628-BBDD13AC-BC51-4595-A7E5-6570C35CEB09

P2093

Q36431628-008353B6-B691-48E6-99FA-232231F76CDA

Q36431628-0093BD50-87A5-4B5D-98CC-F87718E5A7E2

Q36431628-028DE7BC-1F5C-4822-B45E-B2C86430FA5E

Q36431628-08E0C594-F3A3-4B3D-A471-CD5D6A33C172

Q36431628-0F08FDB7-57FE-478B-B75B-58509B2B83B6

Q36431628-0F4F0B44-D698-4B36-A184-AD999B26049B

Q36431628-19B32CF3-187F-4E0D-8EF1-AFCB8B5FA7E2

Q36431628-2B60C75B-206B-4A36-A68E-9B28BB9A49FD

Q36431628-2E842B33-BF0A-4018-BF06-096164FAA82B

Q36431628-301C12AB-1FE5-4A43-96BE-B312AEE0E47F

P2860

Q36431628-02BEDEFB-4422-4DB6-8B0F-B0125493C089

Q36431628-0A910F1F-7FDE-407A-8A74-57738B373679

Q36431628-22AE0279-B7AD-4AFD-BCF0-3740E9A0799B

Q36431628-250B75DF-6541-4C58-8CED-BBBD275013BD

Q36431628-3128FFA0-C640-4286-8A8F-7C5AD24C3102

Q36431628-35384A13-D21F-4DE2-8269-1F69C26F46ED

Q36431628-3CAB5A85-488E-48D8-89BB-045B8AF6EE2E

Q36431628-3E5E542B-5E20-4130-9BA0-24D25DE7A79C

Q36431628-5860AA46-B91C-47A8-A612-960D2694C6BC

Q36431628-59AC85F5-A323-4B00-9B11-3FE14EE21CAC

P304

Q36431628-9CDD4737-C229-4A6E-AB64-8BAB32897332

P31

Q36431628-EB0B4BC3-71C4-4685-B0BF-46C9C295FE05

P356

Q36431628-8401C79C-0131-4DD8-9432-DB20A89187EE

P407

Q36431628-1F0C979A-EFD3-4E10-831F-3E77EF900150

P433

Q36431628-348A39C2-B406-472D-94C9-A30B54891AD8

P478

Q36431628-E3AF4BD0-61F0-4759-A80F-5426DFA7BFD6

P50

Q36431628-0C9AA762-F604-4930-9F93-6E04DFC60F0A

Q36431628-159EDCAA-4EBC-4D95-8370-5CC9F1C11087

Q36431628-163E4462-A8A8-48F0-AF12-8A9355648714

Q36431628-378624E6-EAC0-47A9-A36E-DB544BBB9273

Q36431628-4C78A2FB-3F86-4846-865F-CD922F9F9AC2

Q36431628-8F4BE04A-49FD-4732-8F68-A1E8535D1753

Q36431628-A093F367-737B-42EF-ADF7-40231DA68150

Q36431628-A384897B-C759-487C-9DB8-15CB8A19000A

Q36431628-A415C4BF-5CB7-4902-8255-6CBE887DA734

Q36431628-D2FADC3D-5898-4632-B2E7-B2876639FDC9

P577

Q36431628-E6FE038B-34B3-429A-92EE-14ECFC4E8192

P5875

Q36431628-8F804A54-5A20-41C0-A433-984BF7275CE7

P698

Q36431628-1F0B3438-3266-474F-B0CA-301EB2CE95FB

P932

Q36431628-5F040449-5BD0-44BD-A86D-0162B17B26B0

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Differential Clinicopathologic ...... illary Thyroid Cancer Variants

@en

P2093

Agnieszka Czarniecka

http://www.w3.org/2001/XMLSchema#string

Alfred K Lam

http://www.w3.org/2001/XMLSchema#string

Bela Bendlova

http://www.w3.org/2001/XMLSchema#string

Caterina Mian

http://www.w3.org/2001/XMLSchema#string

Christine J O'Neill

http://www.w3.org/2001/XMLSchema#string

Di Teng

http://www.w3.org/2001/XMLSchema#string

Efisio Puxeddu

http://www.w3.org/2001/XMLSchema#string

Electron Kebebew

http://www.w3.org/2001/XMLSchema#string

Elizabeth H Holt

http://www.w3.org/2001/XMLSchema#string

Federica Vianello

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Integrated genomic characterization of papillary thyroid carcinoma

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors.

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression

Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up.

P304

264-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2015-2917

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Jarząb

Pilar Santisteban

Riccardo Giannini

Garcilaso Riesco-Eizaguirre

Roderick J Clifton-Bligh

P577

2015-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283492543

http://www.w3.org/2001/XMLSchema#string

P698

26529630

http://www.w3.org/2001/XMLSchema#string

P932

4701842

http://www.w3.org/2001/XMLSchema#string